"10.1371_journal.pone.0147262","plos one","2016-01-27T00:00:00Z","E Lecarpentier; M Bhatt; G I Bertin; B Deloison; L J Salomon; P Deloron; T Fournier; A I Barakat; V Tsatsaris","INSERM, UMR-S 1139, Paris, France; PRES Sorbonne Paris Cité, Université Paris Descartes, Paris, France; Port Royal Maternity, Department of Gynecology Obstetrics I, Centre Hospitalier Universitaire Cochin Broca Hôtel Dieu, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpital de Paris, Paris, France; DHU Risques et grossesse, Paris, France; PremUP Foundation, Paris, France; Institut de Recherche pour le Développement (IRD), MERIT - UMR216, Paris, France; Laboratoire dHydrodynamique (LadHyX), CNRS, École Polytechnique, 91128, Palaiseau, France; INSERM U970, Paris Cardiovascular Research Center-PARCC, Paris, France; EA FETUS 7328, Paris, France; Department of Obstetrics and Fetal Medicine, Paris Descartes University, Hôpital Necker-Enfants-Malades, Assistance Publique-Hôpital de Paris, Paris, France","Conceived and designed the experiments: EL LJS PD TF AIB VT. Performed the experiments: EL MB GIB BD. Analyzed the data: EL MB GIB BD AIB VT. Contributed reagents/materials/analysis tools: EL PD TF AIB VT. Wrote the paper: EL GIB AIB VT. Conceived the study: EL. Designed each part of the study: EL LJS PD TF AIB VT. Designed and performed the computational fluid dynamic simulations with the COMSOL software: EL MB. Performed the cytoadhesion experiments: EL GIB. Designed the clinical trial PLACENTIMAGE: BD LJS. Analyzed the data of placental MRI: EL BD. Obtained the permission to use the human red blood cells: GIB PD. Obtained the permission for use of human placenta: TF VT. Analyzed the coherence of the data: EL AIB VT.","The authors have declared that no competing interests exist.","2016","01","E Lecarpentier","EL",9,FALSE,6,4,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
